Lantheus Holdings (LNTH) Curent Deferred Tax Liability (2014 - 2015)
Lantheus Holdings (LNTH) posted quarterly Curent Deferred Tax Liability of $194000.0 for Q4 2015, up 27.63% year-over-year from $152000.0 in Q4 2014, and up 27.63% quarter-over-quarter from $152000.0 in Q4 2014.
Lantheus Holdings (LNTH) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends
Lantheus Holdings (LNTH) has reported Curent Deferred Tax Liability for 2 consecutive years, with $194000.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Curent Deferred Tax Liability rose 27.63% year-over-year to $194000.0; the TTM figure through Dec 2015 stood at $194000.0 (up 27.63% YoY), while the FY2015 annual figure was $194000.0, up 27.63% from the prior year.
- Curent Deferred Tax Liability climbed to $194000.0 in Q4 2015 per LNTH's latest filing, from $152000.0 in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $194000.0 in Q4 2015 and bottomed at $152000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 194,000.00 |
| Dec 31, 2015 | 194,000.00 |
| Dec 31, 2014 | 152,000.00 |
| Dec 31, 2014 | 152,000.00 |